Caroline E Diggins1, Samuel C Russo1, Janet Lo2. 1. Metabolism Unit, Division of Endocrinology, Massachusetts General Hospital, LON-207, 55 Fruit Street, Boston, MA, 02114, USA. 2. Metabolism Unit, Division of Endocrinology, Massachusetts General Hospital, LON-207, 55 Fruit Street, Boston, MA, 02114, USA. jlo@mgh.harvard.edu.
Abstract
PURPOSE OF REVIEW: This review reports on published studies describing metabolic changes associated with antiretroviral therapy (ART) to treat HIV disease including a historical perspective of earlier ART agents, but with the main focus on newer ART agents currently in use. RECENT FINDINGS: Studies from different countries around the world have shown that integrase inhibitor (INSTI)-based regimens as well as tenofovir alafenamide (TAF) are associated with weight gain, with women and people of black race at especially high risk. Some studies preliminarily suggest worsened metabolic outcomes associated with this weight gain including adverse effects on glucose homeostasis. Antiretroviral therapy can affect weight, adipose tissue, glucose, and lipids. As obesity is prevalent and increasing among people with HIV, awareness of risk factors for weight gain, including the ART medications associated with greater weight gain, are needed in order to inform prevention efforts. Further research is needed to better understand the long-term health consequences of INSTI- and TAF-associated weight increases.
PURPOSE OF REVIEW: This review reports on published studies describing metabolic changes associated with antiretroviral therapy (ART) to treat HIV disease including a historical perspective of earlier ART agents, but with the main focus on newer ART agents currently in use. RECENT FINDINGS: Studies from different countries around the world have shown that integrase inhibitor (INSTI)-based regimens as well as tenofovir alafenamide (TAF) are associated with weight gain, with women and people of black race at especially high risk. Some studies preliminarily suggest worsened metabolic outcomes associated with this weight gain including adverse effects on glucose homeostasis. Antiretroviral therapy can affect weight, adipose tissue, glucose, and lipids. As obesity is prevalent and increasing among people with HIV, awareness of risk factors for weight gain, including the ART medications associated with greater weight gain, are needed in order to inform prevention efforts. Further research is needed to better understand the long-term health consequences of INSTI- and TAF-associated weight increases.
Authors: D Périard; A Telenti; P Sudre; J J Cheseaux; P Halfon; M J Reymond; S M Marcovina; M P Glauser; P Nicod; R Darioli; V Mooser Journal: Circulation Date: 1999-08-17 Impact factor: 29.690
Authors: Véronique Joly; Philippe Flandre; Vincent Meiffredy; Nicolas Leturque; Marine Harel; Jean-Pierre Aboulker; Patrick Yeni Journal: AIDS Date: 2002-12-06 Impact factor: 4.177
Authors: J R Bogner; V Vielhauer; R A Beckmann; G Michl; L Wille; B Salzberger; F D Goebel Journal: J Acquir Immune Defic Syndr Date: 2001-07-01 Impact factor: 3.731
Authors: Heidi M Crane; Carl Grunfeld; James H Willig; Michael J Mugavero; Stephen Van Rompaey; Richard Moore; Benigno Rodriguez; Betsy J Feldman; Michael M Lederman; Michael S Saag; Mari M Kitahata Journal: AIDS Date: 2011-01-14 Impact factor: 4.177
Authors: Rochelle P Walensky; A David Paltiel; Elena Losina; Lauren M Mercincavage; Bruce R Schackman; Paul E Sax; Milton C Weinstein; Kenneth A Freedberg Journal: J Infect Dis Date: 2006-06-01 Impact factor: 5.226
Authors: M A Valantin; R Bittar; P de Truchis; D Bollens; L Slama; P Giral; D Bonnefont-Rousselot; P Pétour; C Aubron-Olivier; D Costagliola; C Katlama Journal: J Antimicrob Chemother Date: 2010-01-06 Impact factor: 5.790
Authors: Andrew Carr; Cassy Workman; Don E Smith; Jennifer Hoy; Jeff Hudson; Nicholas Doong; Allison Martin; Janaki Amin; Judith Freund; Matthew Law; David A Cooper Journal: JAMA Date: 2002-07-10 Impact factor: 56.272
Authors: S A Riddler; X Li; H Chu; L A Kingsley; A Dobs; R Evans; F Palella; B Visscher; J S Chmiel; Ar Sharrett Journal: HIV Med Date: 2007-07 Impact factor: 3.180
Authors: Marit G A van Vonderen; Michiel A van Agtmael; Elly A M Hassink; Ana Milinkovic; Kees Brinkman; Suzanne E Geerlings; Matti Ristola; Arne van Eeden; Sven A Danner; Peter Reiss Journal: PLoS One Date: 2009-05-21 Impact factor: 3.240